Imatron posts record Q4 results

Article

Imatron, a South San Francisco, CA-based diagnostic imaging company that creates electron beam tomography heart scanners, posted the highest profits in the company’s history at the end of 1999. Imatron made a revenue gain of $7 million in 1999 over

Imatron, a South San Francisco, CA-based diagnostic imaging company that creates electron beam tomography heart scanners, posted the highest profits in the company’s history at the end of 1999. Imatron made a revenue gain of $7 million in 1999 over the previous year, netting $37.5 million compared to $30.7 million in 1998. Net loss was $6.6 million for the 1999 fiscal year, compared to a net loss of $14.8 million for the prior year. Revenues from continuing operations in the fourth quarter of 1999 increased by 58% to $12.9 million compared to revenues of $8.2 million for the fourth quarter of 1998.

These figures do not include business produced by HeartScan Imaging, a program that enabled customers to visit a clinic and receive a heart scan using the company’s Ultrafast CT scanners. Imatron sold this unprofitable subsidiary in November 1999.

The company attributes its financial high to selling a record seven scanners during the fourth quarter and 19 for the year. This is compared with sales of four scanners in the fourth quarter of 1998 and 15 for that year. In addition, the company increased its manufacturing capacity.

Imatron is confident sales will continue to surge because peer-reviewed journal articles support both coronary artery scanning and electron beam angiography, applications of the company’s proprietary electron beam tomography technology that were recently cleared by the FDA.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.